Cargando…

Correction: Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial

Detalles Bibliográficos
Autores principales:	Choi, Dong-Ju, Park, Chan Soon, Park, Jin Joo, Lee, Hae-Young, Kang, Seok-Min, Yoo, Byung-Su, Jeon, Eun-Seok, Hong, Seok Keun, Shin, Joon-Han, Kim, Myung-A, Park, Dae-Gyun, Kim, Eung-Ju, Hong, Soon-Jun, Kim, Seok Yeon, Kim, Jae-Joong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310476/ https://www.ncbi.nlm.nih.gov/pubmed/35879804 http://dx.doi.org/10.1186/s13063-022-06559-4

Ejemplares similares

Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial
por: Choi, Dong-Ju, et al.
Publicado: (2018)

The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction
por: Choi, Ki Hong, et al.
Publicado: (2019)

Dose proportionality and pharmacokinetics of carvedilol sustained-release formulation: a single dose-ascending 10-sequence incomplete block study
por: Kim, Yo Han, et al.
Publicado: (2015)

Enantioselective Resolution of (R,S)-Carvedilol to (S)-(−)-Carvedilol by Biocatalysts
por: Ettireddy, Swetha, et al.
Publicado: (2017)

Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction
por: Frishman, William H, et al.
Publicado: (2008)

Two-Year Clinical Outcome after Carvedilol-Loaded Stent Implantation in Patients with Coronary Artery Disease
por: Kim, Hyun Kuk, et al.
Publicado: (2011)

Candesartan and carvedilol for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin
por: Lee, Myunhee, et al.
Publicado: (2021)

Carvedilol in hypertension treatment
por: Stafylas, Panagiotis C, et al.
Publicado: (2008)

Carvedilol—NSBB of Choice in All Cirrhotics? Short Title: Carvedilol for Portal Hypertension
por: Tandon, Puneeta, et al.
Publicado: (2015)

Effects of Bisoprolol Are Comparable with Carvedilol in Secondary Prevention of Acute Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention
por: Jun, Seung Jin, et al.
Publicado: (2018)

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007)

Comparative Study of Selected Excipients’ Influence on Carvedilol Release from Hypromellose Matrix Tablets
por: Ojsteršek, Tadej, et al.
Publicado: (2023)

Use of carvedilol in hypertension: an update
por: Leonetti, Gastone, et al.
Publicado: (2012)

Carvedilol in the Treatment of Portal Hypertension
por: Al-Ghamdi, Hamdan
Publicado: (2011)

Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10‐Year Cohort
por: Tang, Chao‐Hsiun, et al.
Publicado: (2016)

Optimization of carvedilol solid lipid nanoparticles: An approach to control the release and enhance the oral bioavailability on rabbits
por: El-Say, Khalid Mohamed, et al.
Publicado: (2018)

Impact of drying on dissolution behavior of carvedilol-loaded sustained release solid dispersion: development and characterization
por: Halder, Shimul, et al.
Publicado: (2020)

Comparison of the Impact of Pharmacogenetic Variability on the PK of Slow Release and Immediate Release Tacrolimus Formulations
por: van Gelder, Teun, et al.
Publicado: (2020)

Preclinical Evidences for an Antimanic Effect of Carvedilol
por: de Souza, Greicy Coelho, et al.
Publicado: (2015)

Carvedilol for the treatment of red scrotum syndrome
por: Merhi, Ribal, et al.
Publicado: (2017)

Hot Melt Coating of Amorphous Carvedilol
por: Bannow, Jacob, et al.
Publicado: (2020)

Physicochemical properties and drug-release mechanisms of dual-release bilayer tablet containing mirabegron and fesoterodine fumarate
por: Lee, Hong-Goo, et al.
Publicado: (2019)

Formulation and development of novel control release transdermal patches of carvedilol to improve bioavailability for the treatment of heart failure
por: Mo, Long, et al.
Publicado: (2022)

β‐Blockers and 1‐Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate
por: Park, Jin Joo, et al.
Publicado: (2019)

Carvedilol Prevents Redox Inactivation of Cardiomyocyte Β(1)-Adrenergic Receptors
por: Park, Misun, et al.
Publicado: (2018)

A simple LC-MS/MS method for pharmacokinetic study of carvedilol and 4/-hydroxyphenyl carvedilol at a low dose
por: Eiamart, Wanna, et al.
Publicado: (2022)

Effects of the beta-blocker carvedilol on arrhythmia and long-term clinical outcomes in benign prostate hypertrophy patients
por: Kim, Soo Jin, et al.
Publicado: (2023)

Effect of hydroxylpropyl-β-cyclodextrin on Solubility of Carvedilol
por: Shewale, B. D., et al.
Publicado: (2008)

Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol
por: Barold, S. Serge, et al.
Publicado: (2018)

Preventive role of carvedilol in adriamycin-induced cardiomyopathy
por: Jhorawat, Rajesh, et al.
Publicado: (2016)

Carvedilol versus Metoprolol in Patients with Ventricular Tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022)

How Carvedilol activates β(2)-adrenoceptors
por: Benkel, Tobias, et al.
Publicado: (2022)

Endothelial Phenotype Evoked by Low Dose Carvedilol in Pulmonary Hypertension
por: Cheong, Hoi I, et al.
Publicado: (2018)

Impact of R-Carvedilol on β2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes
por: Casabella-Ramón, Sergi, et al.
Publicado: (2022)

Transfersome Encapsulated with the R-carvedilol Enantiomer for Skin Cancer Chemoprevention
por: Shamim, Md Abdullah, et al.
Publicado: (2023)

Sevoflurane, Propofol and Carvedilol Block Myocardial Protection by Limb Remote Ischemic Preconditioning
por: Cho, Youn Joung, et al.
Publicado: (2019)

The Effect of Enalapril and Carvedilol on Left Ventricular Dysfunction in Middle Childhood and Adolescent Patients With Muscular Dystrophy
por: Kwon, Hye Won, et al.
Publicado: (2012)

Carvedilol in the treatment of elderly patients with chronic heart failure
por: Witte, Klaus KA, et al.
Publicado: (2008)

Carvedilol dihydrogen phosphate hemihydrate: a powder study
por: Chernyshev, Vladimir V., et al.
Publicado: (2009)

The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial
por: Eichhorn, Eric J, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_fbq2ukun2mcfrfgbcfp2882s8t